All
Childhood skin disease has unique challenges
September 17th 2014Therapeutics is one of the most significant challenges in pediatric dermatology. Children have been identified as “therapeutic orphans”, with few options that have FDA-approved pediatric indications. Access to new and novel treatments like biologics is especially limited. Supportive legislation, beginning with the Best Pharmaceuticals for Children Act (bpca.nichd.nih.gov), has marked the dawn of a new era.
Front office signals first impressions
September 16th 2014When is the last time you took a good look at what your waiting area is signaling to the outside world? It is after all, the first physical impression of your clinic. Perhaps it is time to make some changes, or improve on some already excellent practices.
5 key metrics to measure physician blog success
September 16th 2014Physicians who blog have probably realized that it’s difficult to quantify and measure a blog's success. With so many different metrics available, how do you figure out which ones to focus on? Here are five key metrics that every blogging physician should pay attention to.
Bleach-based gel wash may improve severe atopic dermatitis
September 12th 2014Positive results of an open-label, multicenter trial support the use of a gel body wash containing 0.006 percent sodium hypochlorite (CLn Body Wash, Top MD Skin Care) as an adjunct in the management of atopic dermatitis (AD), according to researchers who presented their findings at the 2014 annual meeting of the American Academy of Dermatology.
TAKEAWAY Incentives to encourage adherence, part 3
September 12th 2014In part 3 of our discussion on patient adherence, Dermatology Times editorial adviser Elaine Siegfried, M.D., continues the discussion with Steven Feldman, M.D., on assessing adherence and intervening to encourage the best possible treatment outcomes. They review a method for developing patient accountability, clinical trial results versus real life, and whole health system incentives for focusing more research in this area. Dr. Feldman is a professor of dermatology at the Wake Forest University School of Medicine, Winston-Salem, N.C.
PODCAST: Incentives to encourage adherence, part 4
September 12th 2014In this last part of our discussion on patient adherence, Dermatology Times editorial adviser, Elaine Siegfried, M.D., continues the discussion with Steven Feldman, M.D., on assessing adherence and intervening to encourage the best possible treatment outcomes.
Experts clarify verrucous hemangioma confusion
September 11th 2014The diagnosis of angiokeratoma circumscriptum should be supplanted with verrucous hemangioma, and the lesion should be treated with surgery in most cases, according to a retrospective case series presented at the annual meeting of the Canadian Dermatology Association.
New guidelines aim to improve acne patient care
September 11th 2014Guidelines for the diagnosis and treatment of pediatric acne developed by the American Acne Rosacea Society (AARS) and endorsed by the American Academy of Pediatrics (AAP) provide the AAP with its first-ever evidence-based guidelines for the management of this very common pediatric condition.
Technology fuels skin reactions
September 10th 2014New sources of pediatric contact dermatitis are found in many of the products used by children, parents and even dermatologists. Recognizing these and other emerging allergens could spell fast, effective relief for pediatric patients, as well as prevent misdiagnoses and long-term unnecessary treatments, an expert says.